We are live on ! Find out more
Renaissance Technologies

Renaissance Technologies Portfolio holdings

AUM $63.9B
1-Year Est. Return 45.56%
 

Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.

This Fund
S&P 500
This Quarter Est. Return
+7.01%
1 Year Est. Return
+45.56%
3 Year Est. Return
+129.95%
5 Year Est. Return
+153.6%
10 Year Est. Return
+738.07%
AUM
$71.6B
AUM Growth
+$8.36B
Cap. Flow
+$5.19B
Cap. Flow %
7.25%
Top 10 Hldgs %
7.9%
Holding
3,652
New
433
Increased
1,585
Reduced
1,146
Closed
462

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$468M
2
JNJ icon
Johnson & Johnson
JNJ
+$440M
3
IBM icon
IBM
IBM
+$355M
4
BKNG icon
Booking.com
BKNG
+$332M
5
RAI
Reynolds American Inc
RAI
+$331M

Sector Composition

Rank Sector Weight
1 Healthcare 15.02%
2 Technology 13.31%
3 Financials 12.25%
4 Industrials 9.65%
5 Consumer Staples 9.54%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RDGT
2926
Ridgetech Inc
RDGT
$935K
$279K ﹤0.01%
4
SMBK icon
2927
SmartFinancial
SMBK
$901M
$278K ﹤0.01%
+13,195
New +$276K
TI
2928
DELISTED
Telecom Italia
TI
$278K ﹤0.01%
+30,800
New +$266K
ANGI icon
2929
Angi Inc
ANGI
$257M
$277K ﹤0.01%
4,860
-49,840
-91% -$3.17M
CDTX
2930
DELISTED
Cidara Therapeutics
CDTX
$277K ﹤0.01%
1,775
-720
-29% -$126K
CBFV icon
2931
CB Financial Services
CBFV
$189M
$275K ﹤0.01%
9,700
-600
-6% -$16K
SRSC
2932
DELISTED
SEARS Canada Inc.
SRSC
$274K ﹤0.01%
203,100
+11,235
+6% +$16.2K
STV
2933
DELISTED
China Digital Tv Hldgs Co Ltd
STV
$272K ﹤0.01%
212,198
-86,515
-29% -$116K
SYRE icon
2934
Spyre Therapeutics
SYRE
$8.53B
$270K ﹤0.01%
+1,448
New +$204K
CXRX
2935
DELISTED
Concordia International Corp. Common Stock
CXRX
$269K ﹤0.01%
165,234
-118,954
-42% -$256K
BNSO
2936
DELISTED
Bonso Electronic International
BNSO
$268K ﹤0.01%
104,100
-11,100
-10% -$26.6K
WSCI
2937
DELISTED
WSI Industries Inc
WSCI
$268K ﹤0.01%
79,500
+1,200
+2% +$3.58K
ELSE icon
2938
Electro-Sensors
ELSE
$27.4M
$267K ﹤0.01%
67,200
+2,200
+3% +$8.9K
SMMT icon
2939
Summit Therapeutics
SMMT
$9.91B
$267K ﹤0.01%
+20,102
New +$232K
PBNC
2940
DELISTED
PARAGON COMMERCIAL CORPORATION
PBNC
$267K ﹤0.01%
+5,000
New +$243K
FUNC icon
2941
First United
FUNC
$288M
$265K ﹤0.01%
18,300
+5,400
+42% +$77.7K
ATTO
2942
DELISTED
Atento S.A.
ATTO
$265K ﹤0.01%
5,769
-338
-6% -$15K
CYTR
2943
DELISTED
CytRx Corp
CYTR
$264K ﹤0.01%
+99,224
New +$251K
SGYP
2944
DELISTED
Synergy Pharmaceuticals, Inc Common Stock
SGYP
$263K ﹤0.01%
+56,534
New +$328K
PRPH
2945
DELISTED
ProPhase Labs
PRPH
$262K ﹤0.01%
11,540
+500
+5% +$10.1K
CBR
2946
DELISTED
CIBER Inc.
CBR
$262K ﹤0.01%
656,100
+208,400
+47% +$94.2K
BAA
2947
DELISTED
Banro Corporation Common Stock
BAA
$261K ﹤0.01%
206,750
-140,566
-40% -$216K
PPSI
2948
Pioneer Power Solutions
PPSI
$32.3M
$260K ﹤0.01%
+34,600
New +$261K
NSAT
2949
DELISTED
Norsat International Inc.
NSAT
$260K ﹤0.01%
26,000
+2,800
+12% +$23.2K
AINC
2950
DELISTED
Ashford Inc.
AINC
$258K ﹤0.01%
4,380
-4,400
-50% -$238K

Similar funds

Renaissance Technologies's Q1 2017 Portfolio in Review

As of Q1 2017, Renaissance Technologies held 3,652 positions worth $71.6B, up 13% from $63.2B the previous quarter. Its ten largest holdings account for 7.9% of the portfolio.

Renaissance Technologies deployed $5.19B of net new capital in Q1 2017, opening 433 new positions and adding to 1,585 existing holdings. Its largest new stake was Merck: 7,716,460 shares worth $468M.

By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 12% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Walt Disney, an estimated $247M trimmed.

  • Renaissance Technologies's largest Q1 2017 buy was Merck: 7,716,460 shares worth $468M.
  • Renaissance Technologies added most to Johnson & Johnson in Q1 2017, an estimated $440M increase.
  • Renaissance Technologies's biggest Q1 2017 reduction was Walt Disney, cutting an estimated $247M.
  • Renaissance Technologies fully exited Linear Technology Corp in Q1 2017, selling an estimated $482M.
  • Renaissance Technologies's ten largest holdings make up 7.9% of its $71.6B portfolio in Q1 2017.
  • Renaissance Technologies opened 433 new positions and closed 462 in Q1 2017.
  • Renaissance Technologies's portfolio value rose 13% quarter-over-quarter to $71.6B.

Based on Renaissance Technologies's 13F filing for Q1 2017, filed 12 May 2017.